Welcome to our dedicated page for AIOS Tech news (Ticker: AIOS), a resource for investors and traders seeking the latest updates and insights on AIOS Tech stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AIOS Tech's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AIOS Tech's position in the market.
AIOS Tech (Nasdaq: AIOS) approved a 20-for-1 share consolidation effective April 27, 2026, and simultaneously increased authorized share capital.
The consolidation will combine every 20 shares into one, reduce issued Class A shares from 64,985,096 to ~3,249,255, change the CUSIP to G6593L130, and aims to regain compliance with Nasdaq Rule 5550(a)(2).
AIOS Tech (NASDAQ: AIOS) received a Nasdaq notice on April 1, 2026 that its 30-day closing bid fell below the $1 minimum under Rule 5550(a)(2). Nasdaq granted a 180-calendar-day compliance period ending September 28, 2026, to regain compliance, with a possible additional 180 days if certain standards are met.
The notification does not affect current listing or trading. The company is evaluating options to regain compliance but offered no assurance it will succeed.